Knowles Reports Strong Q1 Results, Exceeds Guidance, and Issues Positive Q2 Outlook
Summary
Knowles Corporation announced strong Q1 2026 financial results, surpassing guidance with 16% revenue growth and 50% non-GAAP EPS growth year-over-year, and provided an optimistic outlook for Q2 2026.
Key Events
-
Strong Q1 2026 Financial Performance
Knowles reported Q1 2026 revenues of $153.1 million, a 16% increase year-over-year, and non-GAAP diluted EPS from continuing operations of $0.27, up 50% year-over-year. Both metrics were at or above the high end of the company's guided ranges.
-
Positive Q2 2026 Outlook Provided
For the second quarter of 2026, Knowles projects revenues from continuing operations to be between $152 million and $162 million, with non-GAAP diluted EPS from continuing operations expected in the range of $0.28 to $0.32.
-
Growth Driven by Strategic Execution and Market Trends
Management highlighted strong execution of its strategy, leveraging unique technologies and customer intimacy. Growth was attributed to increased demand and new design wins in Medtech, Defense, Industrial, and Electrification markets, which are benefiting from strong secular trends.
Analysis
Knowles Corporation delivered robust first-quarter results, with revenues and non-GAAP diluted EPS exceeding the high end of their guided ranges. The company achieved significant year-over-year growth in both top and bottom lines, driven by increased demand and new design wins across its Medtech, Defense, Industrial, and Electrification end markets. Management expressed confidence in continued organic revenue and adjusted EBITDA growth, citing a healthy backlog and ongoing strategic execution. This strong performance, coupled with a positive outlook for Q2, reinforces the company's current market position, especially as the stock trades near its 52-week high.
At the time of this filing, KN was trading at $31.01 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $14.78 to $31.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.